Patents by Inventor Frank J. Grant

Frank J. Grant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TESTIS-SPECIFIC RECEPTOR
    Publication number: 20030100046
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in testis cells. The polypeptides may be used within methods for detecting ligands that promote the proliferation and/or differentiation of testis cells, and may also be used in the development of male-specific contraceptives and infertility treatments.
    Type: Application
    Filed: March 12, 1997
    Publication date: May 29, 2003
    Inventors: JAMES W. BAUMGARTNER, THERESA M. FARRAH, DONALD C. FOSTER, FRANK J. GRANT, PATRICK J. O'HARA
  • TESTIS-SPECIFIC RECEPTOR
    Publication number: 20030100047
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular domain of a cell-surface receptor that is expressed in testis cells. The polypeptides may be used within methods for detecting ligands that promote the proliferation and/or differentiation of testis cells, and may also be used in the development of male-specific contraceptives and infertility treatments.
    Type: Application
    Filed: June 4, 1998
    Publication date: May 29, 2003
    Inventors: JAMES W. BAUMGARTNER, THERESA M. FARRAH, DONALD C. FOSTER, FRANK J. GRANT, PATRICK J. O'HARA
  • Hematopoietic cytokine receptor
    Patent number: 6080406
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular ligand-binding domain of a cell-surface receptor that is expressed at high levels in lymphoid tissue, including B-cells and T-cels. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo.
    Type: Grant
    Filed: March 24, 1999
    Date of Patent: June 27, 2000
    Assignee: ZymoGenetics, Inc.
    Inventors: James W. Baumgartner, Donald C. Foster, Frank J. Grant, Cindy A. Sprecher
  • Hematopoietic cytokine receptor
    Patent number: 5925735
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular ligand-binding domain of a cell-surface receptor that is expressed at high levels in lymphoid tissue, including B-cells and T-cells. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo.
    Type: Grant
    Filed: May 6, 1998
    Date of Patent: July 20, 1999
    Assignee: ZymoGenetics, Inc.
    Inventors: James W. Baumgartner, Donald C. Foster, Frank J. Grant, Cindy A. Sprecher
  • Hematopoietic cytokine receptor
    Patent number: 5792850
    Abstract: Novel receptor polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods are disclosed. The polypeptides comprise an extracellular ligand-binding domain of a cell-surface receptor that is expressed at high levels in lymphoid tissue, including B-cells and T-cells. The polypeptides may be used within methods for detecting ligands that stimulate the proliferation and/or development of lymphoid and myeloid cells in vitro and in vivo. Ligand-binding receptor polypeptides can also be used to block ligand activity in vitro and in vivo.
    Type: Grant
    Filed: May 23, 1996
    Date of Patent: August 11, 1998
    Assignee: ZymoGenetics, Inc.
    Inventors: James W. Baumgartner, Donald C. Foster, Frank J. Grant, Cindy A. Sprecher